St. Anna Children's Cancer Research Institute (CCRI)
Dr. Sara Wernig-Zorc is a postdoctoral researcher at St. Anna Children's Cancer Research Institute, involved in joint research within the Taschner-Mandl and Halbritter labs since July 2022. Previously, Dr. Wernig-Zorc completed a PhD in RNA biology and bioinformatics at the University of Regensburg from March 2018 to June 2022 and served as a research associate and bioinformatician at the Sahlgrenska Academy at the University of Gothenburg from June 2015 to February 2018. Dr. Wernig-Zorc's academic foundation includes an MSc in genomics and systems biology from the University of Gothenburg, a BSc in biotechnology from the University of Ljubljana, and a BSc in molecular biology from the University of Aberdeen. Currently, Dr. Wernig-Zorc is pursuing a Global Clinical Scholars Research Training Certificate at Harvard Medical School, focusing on clinical trials.
This person is not in any offices
St. Anna Children's Cancer Research Institute (CCRI)
The St. Anna Children's Cancer Research Institute (St Anna CCRI), located in the center of Vienna, the world's most livable city and one of Europe's most important places for biomedical research and life sciences, is an internationally renowned multidisciplinary research institution with the aim to develop and optimize diagnostic, prognostic, and therapeutic strategies for the treatment of children and adolescents with cancer. To achieve this goal we combine basic research with translational and clinical research and focus on the specific characteristics of childhood tumor diseases in order to provide young patients with the best possible and most innovative therapies. Dedicated research groups in the fields of tumor genomics and epigenomics, immunology, molecular biology, cell biology, bioinformatics and clinical research are working together to harmonize scientific findings with the clinical needs of physicians to ultimately improve the wellbeing of our patients. Through close cooperation between clinic and research, the CCRI provides an ideal environment for cutting-edge research and its translation into clinical practice. To achieve our ultimate goal of advancing the well-being of patients, the CCRI constantly pushes scientific boundaries and strongly promotes close collaboration and exchange with external institutions like the Medical University of Vienna, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA) and the Institute of Molecular Pathology (IMP).